Mesopores Silica and Chitosan Coated Nanoparticles for Targeted Controlled Drug Delivery in Pancreatic Cancer Therapy
Keywords:
Nanoparticles, Pancreas, CancerAbstract
Pancreatic cancer is a very aggressive and fatal cancer that is often diagnosed late with limited therapeutic choices. Conventional chemotherapy is faced with considerable limitations such as low drug bioavailability, systemic toxicity, and rapid clearance of drugs, leading to less-than-optimal therapeutic effects. Targeted drug delivery systems have now become a promising field to avoid these limitations. Among the other nanocarriers, chitosan-coated nanoparticles and mesoporous silica nanoparticles (MSN) are prospective carriers for targeted and controlled delivery of anticancer drugs in cancer treatment because of their distinguished physicochemical properties, including high surface area, tunable pore size, and biocompatibility.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
